HIGHLIGHTS
- who: Krzysztof Kalwak from the (UNIVERSITY) have published the paper: Treosulfanu280dfludarabineu280dthiotepa-based conditioning treatment before allogeneic hematopoietic stem cell transplantation for pediatric patients with hematological malignancies, in the Journal: (JOURNAL)
- what: The aim of this phase II trial was to describe the safety and efficacy of treosulfan administered as part of a standardized fludarabine-containing conditioning treatment and to contribute to a PK model. The authors report the final results of the first prospective alloHSCT trial of a treosulfan/fludarabine/thiotepa combination regimen (FTT; 65 of 70 trial patients treated) administered to children and adolescents . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.